Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps3-29-01 | Treatment 2 | ETA2023

Impact of local treatments in progressive, advanced, radioiodine-refractory thyroid cancer

Esposito Gerardo , Lorusso Loredana , Minaldi Elisa , bottici valeria , molinaro eleonora , elisei rossella , agate laura

Introduction: The majority of patients with radioiodine-refractory thyroid carcinoma (RAIR-TC) have an indolent disease and require active surveillance (AS) only, while those with progression of the disease (PD) may benefit from local treatment (LT) or systemic therapy with tyrosine-kinase inhibitors (TKI). In the literature, no data about the real impact of LTs in avoiding/delaying systemic treatment in RAIR-TC patients are present.Objective: This study...

ea0093oc29 | Oral communication 4: Pituitary and Neuroendocrinology | EYES2023

Folliculo-stellate cells in nonfunctioning pituitary neuroendocrine tumors

Nastase Valeria Nicoleta , Burcea Iulia Florentina , Ceausu Amalia Raluca , Poiana Catalina , Raica Marius

Introduction: Folliculo-stellate cells (FSCs), non-endocrine star-like shaped population of cells located in the anterior pituitary, have very heterogenous function and phenotype. Located between the secretory cells, their first atributed role was connected to a supporting network. In literature, they were mentioned to be involved in the pathogenesis and evolution of pituitary neuroendocrine tumors (PitNETs).Objectives: Analyse FSCs characteristics and d...

ea0093oc53 | Oral communication 8: Interdisciplinary Endocrinology and Environment, Society and Governance | EYES2023

Metabolic and growth outcome of two-years growth hormone treatment in children born small for gestational age (SGA): A retrospective study

Ferrigno Rosario , Savanelli Maria Cristina , Cioffi Daniela , Pellino Valeria , Klain Antonella

Children born small for gestational age (SGA) not showing catch-up growth in early life may show decreased growth rate and adult height and worse metabolic profile compared to general population. In these patients, growth hormone (GH) treatment showed positive effects on growth rate and metabolic profile, with good tolerability. The aim of the study was to evaluate auxological and metabolic effects and safety of GH treatment in SGA children. Study included 34 SGA children (15 ...

ea0090p115 | Endocrine-related Cancer | ECE2023

Hand-foot syndrome: a frequent but rarely severe adverse event in patients with thyroid cancer treated with lenvatinib

Minaldi Elisa , Cappagli Virginia , Giani Carlotta , Valerio Laura , Lorusso Loredana , Matrone Antonio , Gambale Carla , Prete Alessandro , Puleo Luciana , Bottici Valeria , Molinaro Eleonora , Agate Laura , Elisei Rossella

Introduction: Hand-foot syndrome (HFS), or palmo-plantar erythrodysplasia, is an adverse event related to lenvatinib therapy. In the clinical trial (SELECT study) HFS was reported in 32% of patients, but only 3% was grade ≥3. In real-life studies the frequency was variable: between 8 and 55%.Patients: We collected clinical and pathological data about 165 patients with thyroid cancer treated with lenvatinib, followed up between 2012 and 2022 at the ...

ea0051oc4.3 | Oral Communications 4 | BSPED2017

Novel FOXA2 mutation causes hyperinsulinism, hypopituitarism with craniofacial dysmorphism and endoderm-derived organ abnormalities

Giri Dinesh , Vignola Marial Lillina , Gualtieri Angelica , Scagliotti Valeria , McNamara Paul , Peak Matthew , Didi Mohammed , Gaston-Massuet Carles , Senniappan Senthil

Background: Congenital hypopituitarism (CH) is characterised by the deficiency of one or more pituitary hormones and can present alone or in association with complex disorders. Congenital hyperinsulinism (CHI) is a disorder of unregulated insulin secretion despite hypoglycaemia that can occur in isolation or as part of a syndrome. The underlying genetic etiology causing the complex phenotype of CH and CHI is unknown.Patient and Methods: A female baby bor...

ea0081oc3.5 | Oral Communications 3: Thyroid 1 | ECE2022

Functional analysis of exosomal miRNAs secreted by thyroid cancer cells

Verrienti Antonella , Maggisano Valentina , Capriglione Fancesca , Sponziello Marialuisa , Pecce Valeria , Durante Cosimo , Celano Marilena , Bulotta Stefania , Russo Diego

Background: MiRNAs transported by exosomes play a role in various processes of tumorigenesis and tumor progression. They can function as oncogenes able to structurally and biologically change the tumor microenvironment (TME) therefore playing a crucial role in cell-to-cell communication during tumor development and allowing cancer cells to become invasive and disseminate from the primary site to distant locations.We aimed to identify the exosome miRNAs that may be involved in ...

ea0081oc12.3 | Oral Communications 12: Reproductive and Developmental Endocrinology | ECE2022

Defective Notch1/Jag1 signaling impacts GnRH development and contributes to hypogonadotropic hypogonadism

Ludovica Cotellessa , Federica Marelli , Duminuco Paolo , Lucia Bartoloni , Michela Adamo , Pitteloud Nelly , Persani Luca , Bonomi Marco , Giacobini Paolo , Valeria Vezzoli

The precise development of the Gonadotropin Releasing Hormone (GnRH) neurons is essential for the proper function of the hypothalamic-pituitary-gonadal axis, as GnRH is the master regulator of reproductive functions in vertebrates. Mutations in genes involved in the development of GnRH neurons are associated with Congenital Hypogonadotropic Hypogonadism (CHH), a heterogeneous genetic disorder characterized by hypogonadism, lack of puberty onset, and infertility, which is named...

ea0081p688 | Pituitary and Neuroendocrinology | ECE2022

Implications of the 2017 WHO classification in the characterization of GH-secreting pituitary tumors

Burcea Iulia Florentina , Nicoleta Nastase Valeria , Raluca Ceausu Amalia , Dumitraşcu Anda , Maria Cimpean Anca , Raica Marius , Poiana Catalina

Introduction: Somatotroph pituitary adenomas (PAs) represent 10-15% of all resected PAs, exhibiting immunohistochemical (IHC) positivity for GH (growth hormone) and PIT-1 transcription factor (TF). The histopathological (HP) and IHC variability of each PA influences the phenotype, radiological features, and therapy response.Materials and methods: The study included 33 patients with acromegaly, with men: women ratio of 17:16. The HP-IHC characteristics we...

ea0081ep869 | Reproductive and Developmental Endocrinology | ECE2022

Procoagulant imbalance in male hypogonadism and effect of short-term testosterone replacement therapy

Indirli Rita , Clerici Marigrazia , Lanzi Valeria , Profka Eriselda , Cangiano Biagio , Bonomi Marco , Arosio Maura , Mantovani Giovanna , Tripodi Armando , Ferrante Emanuele

Introduction: The effects of testosterone on coagulation have not yet been clarified. In particular, it is still controversial whether male hypogonadism, or testosterone replacement therapy (TRT), may slightly increase the risk of venous thromboembolism, in particular during the first months of therapy. This study aimed to assess the hemostatic balance in hypogonadal men before and after short-term TRT, compared to healthy controls.Methods: Thrombin gene...

ea0084op-09-45 | Oral Session 9: Thyroid Cancer Clinical | ETA2022

The phenotype correlated with RET V804 germline mutation is characterized by the presence of medullary thyroid cancer alone

Romei Cristina , Ramone Teresa , Casalini Roberta , Ciampi Raffaele , Matrone Antonio , Cappagli Virginia , Bottici Valeria , Molinaro Eleonora , Elisei Rossella

Background: Genotype-phenotype correlations between various RET mutations and clinical manifestations of MEN 2 syndrome are well established. A discussion is still open if the FMTC phenotype really exists or if it is just a MEN2A variant. Aim of this study was to verify if the phenotype corresponding to the V804M germline mutation is restricted to FMTC.Methods: During the last 25 years, we have identified 200 families with a hereditary form of M...